BOSTON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Black Kite, the leader in third-party cyber risk intelligence, today announced that it was recognized with the “Red Dot” distinction for the 2024 Red Dot ...
SANTA MONICA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Kite Pharma, Inc. (NASDAQ: KITE) (“Kite”) and Cell Design Labs, Inc. today announced a research collaboration and license agreement to develop ...
Gilead Sciences and its Kite cell therapy subsidiary have agreed to acquire Cell Design Labs for up to approximately $567 million, in a deal designed to grow the buyers’ footprint in chimeric antigen ...